Nutex Health (NUTX) Common Equity (2010 - 2026)

Nutex Health (NUTX) has 17 years of Common Equity data on file, last reported at $442.1 million in Q1 2026.

• Quarterly Common Equity rose 73.17% year-over-year to $442.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $442.1 million (up 73.17% YoY) and the FY2025 annual result came in at $423.4 million, up 124.6% from the prior year.
• Common Equity climbed to $442.1 million in Q1 2026 per NUTX's latest filing, from $423.4 million in the prior quarter.
• The five-year high for Common Equity was $556.1 million in Q2 2022, with the low at $79.1 million in Q4 2023.
• Average Common Equity over 5 years is $212.0 million, with a median of $132.5 million recorded in 2022.
• Year-over-year, Common Equity slumped 80.54% in 2023 and surged 310.72% in 2025.
• Nutex Health's Common Equity stood at $120.3 million in 2022, then sank by 34.26% to $79.1 million in 2023, then jumped by 138.33% to $188.5 million in 2024, then jumped by 124.6% to $423.4 million in 2025, then rose by 4.4% to $442.1 million in 2026.
• Business Quant data shows NUTX's Common Equity at $442.1 million in Q1 2026, $423.4 million in Q4 2025, and $317.2 million in Q3 2025.